Crispr Therapeutics AG (CRSP)
Market Closed
15 Jun, 20:00
$
52. 61
+2.81
+5.6426%
$
4.8B Market Cap
- P/E Ratio
- Div Yield
1.83M Volume
-2.71 Eps
$ 49.8
Previous Close Want to track CRSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crispr Therapeutics AG (CRSP) Statistics
Valuation metrics
Market Cap 4.8B
Enterprise value 5.17B
Trailing P/E (ttm) -8.41
Forward P/E -13.2
PEG ratio 0.26
Price/Sales (ttm) 1,170.64
Price/Book (mrq) 2.64
Enterprise Value/Revenue 1,259.44
Enterprise Value/EBITDA -10.23
Overview
Shares outstanding 96.39M
Float 96.02M
Shares short 22.48M
% Held by insiders 0.06%
% Held by institutions 0.72%
Average volume (10 days) 1.21M
Average volume (90 days) 1.7M
Price summary
52-Week low 40.76
52-Week high 78.48
Beta 1.74
50-Day moving average 51.62
200-Day moving average 53.14
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 333,333:100,000
Last split Date 19 Jul 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -138.57%
Operating margin -134.08%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.31%
Income Statement
Revenue (ttm) 4.1M
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) 0.69%
Gross profit (ttm) -478.71M
EBITDA -531.08M
Net income to common (ttm) -568.53M
Diluted EPS (ttm) -5.92
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 2.44B
Total cash per share (mrq) 25.42
Total debt (mrq) 787.64M
Total Debt/Equity (mrq) 0.43
Current ratio (mrq) 17.96%
Book value per share (mrq) 18.89
Cash Flow
Cash flow statement -399.96M
Levered free cash flow (LFCF) -260.9M
